Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia

@article{Craig2016CriticalRF,
  title={Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia},
  author={Colleen M Craig and Li-fen Liu and Carolyn F Deacon and Jens Juul Holst and Tracey L McLaughlin},
  journal={Diabetologia},
  year={2016},
  volume={60},
  pages={531-540}
}
Aims/hypothesisPost-bariatric hypoglycaemia (PBH) is a rare, but severe, metabolic disorder arising months to years after bariatric surgery. It is characterised by symptomatic postprandial hypoglycaemia, with inappropriately elevated insulin concentrations. The relative contribution of exaggerated incretin hormone signalling to dysregulated insulin secretion and symptomatic hypoglycaemia is a subject of ongoing inquiry. This study was designed to test the hypothesis that PBH and associated… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

Glucagon-like peptide 1 (GLP-1)

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia

VIEW 6 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery

VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

A (2016) GLP-1 is not the key mediator of the health benefits of metabolic surgery

  • J Vidal, A De Hollanda, Jiménez
  • Surg Obes Relat Dis
  • 2016
VIEW 2 EXCERPTS

GLP-1 is not the key mediator of the health benefits of metabolic surgery.

Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor.

  • Jens Juul Holst, Sten Madsbad
  • Medicine
  • Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
  • 2016
VIEW 2 EXCERPTS